Skip to main content

Addressing the threat of Antimicrobial Resistance for better cancer care outcomes

About UICC's Master courses
Master courses are online courses purpose-built to address priority subjects in cancer control or meet specific needs raised by UICC members. Using faculty-led asynchronous learning (i.e. where learning happens on own schedule, within a certain timeframe) and a modular sequential format (i.e. in which a subject is divided in modules that become accessible only once previous ones have been completed), Master courses combine pre-recorded material with assignments, quizzes and discussion forum activities.

Overview of this course
Antimicrobial resistance (AMR) is a growing public health issue that needs urgent attention around the world. Infections become drug-resistant when bacteria adapts, developing the ability to resist the drugs designed to kill them. The result is that many antibiotics are becoming less effective at treating illnesses, and without effective antibiotics, routine surgery and lifesaving treatments like chemotherapy, can become life-threatening.
The purpose of this course is to increase awareness on AMR among cancer professionals, broaden the knowledge of the cancer community on the importance of addressing this issue as an integral part of cancer care and promote best practices addressing AMR globally.

Learning objectives
After completion of the course participants will be able to:

  1. Describe what antimicrobial resistance is and how it has become a public health issue.
  2. Understand how antimicrobial resistance negatively impacts cancer care outcomes globally and in their own setting.
  3. Explain the approaches used to tackle the global threat of antimicrobial resistance and potential solutions to address this threat.
  4. Learn about national action plans for antimicrobial resistance (NAPs) and understand the importance of their implementation.
  5. Gain an insight into the role of access to medicines and infectious disease diagnostics in addressing AMR.
Target audience
The course is designed for cancer advocates, representatives of cancer societies, patient groups, oncology professionals, cancer programme managers, the private sector and other stakeholders working in the field of cancer.

Timeframe
The course will run from 6 September 2021 to 16 January 2022 with learning modules being released at regular intervals:
  • Module 1: Why should the cancer community care about AMR?
  • Module 2: Influencing policy change with data and surveillance.
  • Module 3: Infection control and rational use of medicines
  • Module 4: Access to antimicrobials and infectious disease diagnostics.